CONSERVE FEMORAL RESURFACING COMPONENT— 510(k) K062960

Name: FDA 510(k) clearance K062960
Creator: U.S. Food and Drug Administration
Published: 2006-12-01

Substantially Equivalent

Wrightmedicaltechnologyinc

FDA 510(k) clearance K062960 for CONSERVE FEMORAL RESURFACING COMPONENT, Substantially Equivalent on 2006-12-01. Applicant: Wrightmedicaltechnologyinc. Device class: 2.

Clearance details

Applicant: Wrightmedicaltechnologyinc
Product code: Code KXA
Device class: Class 2
Regulation: 21 CFR 888.3400
Advisory panel: Orthopedic
Date received: 2006-09-29
Decision date: 2006-12-01
Decision: Substantially Equivalent
Clearance type: Special
Location: Arlington, TN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KXA

view all

K201219 — Biocore9 Femoral Head Resurfacing Component2021-01-19
K092198 — CORMET CEMENTLESS RESURFACING FEMORAL HEAD2010-04-15
K082673 — CONSERVE PRESSFIT FEMORAL COMPONENT2008-12-12
K071053 — RECAP HA PRESS-FIT FEMORAL RESURFACING HEAD2007-06-29
K070292 — DUROM HIP RESURFACING SYSTEM, FEMORAL COMPONENTS2007-04-26

More clearances from Wrightmedicaltechnologyinc

view all

K222835 — Prophecy Preoperative Navigation Alignment System2023-01-27
K213342 — PRO-DENSE LoVisc Bone Graft Substitute2022-01-05
K212996 — Sterile PHALINX Hammertoe System2021-11-16
K202815 — PROPHECY Preoperative Navigation Alignment System2021-03-10
K201259 — ORTHOLOC 2 with 3Di Technology Pilon Fracture Plating System2021-01-08

Adverse events under product code KXA

product code KXA

Injury: 324
Total: 324

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.